gimli

ELANTAS stock AI analysis

ELANTAS Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

ELANTAS BECK INDIA LTD. is a small-cap stock in Chemicals. This Gimli page shows the latest available ELANTAS price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive ELANTAS stock page

Price

₹14,228.00

1W return

+6.20%

1M return

+21.59%

3M return

+35.43%

6M return

n/a

1Y return

n/a

Market cap

₹n/a

n/a

ROE

+18.94%

ROCE

n/a

RSI

67.81

Turnover

₹4.46 cr

Why it can matter in screens

Momentum: ELANTAS is above 50DMA, below 200DMA; RSI is 67.81.
Returns: 1D +3.96%, 1W +6.20%, 1M +21.59%, 3M +35.43%, 1Y n/a.
Trend levels: 52W high ₹14,890.00, 52W low ₹9,016.50, off high -4.45%.
Liquidity: latest turnover is ₹4.46 cr; volume vs 20D is +0.61%.
Valuation/profitability: PE n/a, PB n/a, ROE +18.94%, ROCE n/a.
Growth: 3Y sales CAGR +2.99%, 3Y profit CAGR +3.32%.

Quick Answers

What is the latest ELANTAS stock price?

The latest stored price for ELANTAS is Rs 14,228.00 as of 2026-09-18.

Is ELANTAS above its 50DMA and 200DMA?

ELANTAS is above 50DMA, below 200DMA. The latest 50DMA is 11,269.22 and the latest 200DMA is n/a.

What are ELANTAS PE, ROE and ROCE?

ELANTAS has PE n/a, ROE +18.94%, and ROCE n/a in Gimli's latest available snapshot.

How has ELANTAS performed recently?

ELANTAS has returned +21.59% over 1 month, +35.43% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	283.39 cr	100.98 cr	70.86 cr	89.39
2026-03-31	222.17 cr	46.31 cr	31.08 cr	39.21
2025-12-31	215.20 cr	58.81 cr	39.37 cr	49.66
2025-09-30	223.75 cr	54.38 cr	36.26 cr	45.74
2025-06-30	209.93 cr	58.10 cr	39.29 cr	49.56
2025-03-31	206.13 cr	49.03 cr	32.87 cr	41.46
2024-12-31	196.97 cr	45.03 cr	29.74 cr	nan

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2025-12-31	845.90 cr	220.32 cr	147.78 cr	186.41
2025-03-31	895.94 cr	220.32 cr	147.78 cr	186.41
2024-12-31	746.01 cr	199.14 cr	139.56 cr	176.05
2024-03-31	803.28 cr	199.14 cr	139.56 cr	176.05
2023-12-31	677.70 cr	196.09 cr	137.30 cr	173.18

Balance sheet

Period	Assets	Cash	Debt	Equity
2025-12-31	1,166.37 cr	65.97 cr	n/a	1,008.21 cr
2024-12-31	1,015.34 cr	139.62 cr	n/a	867.12 cr
2023-12-31	880.53 cr	3.23 cr	n/a	731.99 cr
2022-12-31	717.49 cr	5.86 cr	n/a	598.60 cr

Cash flow

Period	OCF	FCF	Cash change
2025-12-31	127.11 cr	96.23 cr	n/a
2024-12-31	63.22 cr	-81.92 cr	n/a
2023-12-31	133.42 cr	121.06 cr	n/a
2022-12-31	82.95 cr	75.53 cr	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SOLARINDS	SOLAR INDUSTRIES (I) LTD	167,904.38 cr	84.314744	+35.93%	+26.94%
PIDILITIND	PIDILITE INDUSTRIES LTD	160,004.45 cr	60.281452	+25.27%	+2.95%
SRF	SRF LTD	74,457.19 cr	34.443333	+16.21%	-14.49%
COROMANDEL	COROMANDEL INTERNTL. LTD	58,928.92 cr	32.377284	+14.95%	-13.24%
LINDEINDIA	LINDE INDIA LIMITED	53,230.13 cr	96.965414	+13.58%	-3.17%
FLUOROCHEM	GUJARAT FLUOROCHEM LTD	50,384.90 cr	87.171106	+7.60%	+23.51%
FACT	FACT LTD	49,449.24 cr	-1248.718238	-2.91%	-22.73%
UPL	UPL LIMITED	48,961.82 cr	23.550659	+5.26%	-17.02%

Try these prompts

Analyze ELANTAS BECK INDIA. with valuation, momentum and industry peers
Compare ELANTAS with other Chemicals stocks
Show small-cap stocks in Chemicals above 50DMA with positive 1M return
Find Chemicals stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-09-18. Not investment advice.